ABSTRACT
Xist non-coding RNA (ncRNA) is essential for X chromosome inactivation (XCI). Some genes can escape from XCI, but how this occurs is unknown. We developed a modified RNA tagging and recovery of associated proteins (TRAP) method to study the association between Xist RNA and its target genes. In mouse cells, Xist RNA was detected on the Uba1 gene, but not on Jarid1c and Utx genes, which escape from XCI. Using this technique we were able to show that the Xist RNA molecule is not present on active genes that escape from XCI, but is present on genes inactivated by XCI, suggesting that this method is a powerful tool for functional analysis of ncRNA.
Subject(s)
Chromatin/genetics , Chromatin/metabolism , RNA, Untranslated/genetics , RNA, Untranslated/metabolism , X Chromosome Inactivation/genetics , X Chromosome/genetics , X Chromosome/metabolism , Animals , Cell Line , Chromatin Immunoprecipitation , DNA/genetics , DNA/metabolism , Female , Gene Expression , In Situ Hybridization , In Situ Hybridization, Fluorescence , Male , Mice , RNA, Long Noncoding , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
BACKGROUND: Retroperitoneoscopic surgery was performed on a 41-year-old man with a retrocaval ureter. METHODS: The retrocaval segment of the ureter was retroperitoneoscopically separated and the ureter was reanastomosed using an automatic suture device. RESULTS/DISCUSSION: He returned to normal activities four days postoperatively. Postoperative excretory urography showed improvement of hydronephrosis and no residual stenosis.
Subject(s)
Laparoscopy/methods , Retroperitoneal Space/surgery , Ureter/abnormalities , Ureter/surgery , Adult , Humans , Hydronephrosis/etiology , Male , Treatment Outcome , Ureter/diagnostic imaging , Ureteral Calculi/complications , Ureteral Calculi/surgery , UrographyABSTRACT
OBJECTIVES: To study the clinical effectiveness of the 200-microm holmium laser fiber for endoscopic management of upper urinary tract lesions. METHODS: From January 1997 to March 1998, we performed retrograde endoscopic treatment in 25 patients with urinary tract lesions using a 200-microm holmium laser fiber. Nineteen patients had 20 stones (16 ureteral, 3 lower calyx, and 1 middle calyx), 4 had bleeding lesions in the lower calyx, 1 had transitional cell carcinoma involving the renal pelvis and upper calyx, and 1 had a ureteral stricture associated with an impacted ureteral stone. We used a 7.5F flexible ureterorenoscope for renal and upper ureteral lesions, and a 6.9F rigid ureteroscope for mid and lower ureteral lesions. For treatment, we used a holmium:yttriumaluminum-garnet laser generator and a 200-microm flexible quartz fiber. RESULTS: All stones were successfully fragmented, including three lower caliceal stones. Lower caliceal bleeding spots were successfully cauterized for hemostasis in all 4 patients, and the pelvic tumor was successfully vaporized and ablated. In 1 patient, we had previously failed to treat a ureteral stricture with a 365-microm fiber because of inadequate visualization, but it was successfully incised using the 200-microm fiber. There were no significant complications such as ureteral obstruction or stenosis. CONCLUSIONS: The improved flexibility of the new 200-microm holmium laser fiber facilitates treatment of stones, tumors, strictures, and lesions in the lower calyx, where access is difficult when using the previously available 365-microm fiber.
Subject(s)
Kidney Calculi/therapy , Kidney Calices , Lithotripsy, Laser , Ureteral Calculi/therapy , Ureteroscopy , Adult , Aged , Aged, 80 and over , Female , Humans , Japan , Lithotripsy, Laser/methods , Male , Middle Aged , UreteroscopesABSTRACT
A 39-year-old man with chief complaints of aphasia, disorientation and acalculia was admitted to our hospital. He was diagnosed as a clinically probable case of multiple sclerosis (MS) and his symptoms improved while on steroid pulse therapy. The patient had been diagnosed as having diabetes mellitus 16 years before the onset of MS and his insulin secretion further decreased with time. Slight insulin resistance was observed during a euglycemic hyperinsulinemic clamp study. These results suggested that this patient developed diabetes mellitus mainly due to the decrease of insulin secretion.
Subject(s)
Autoimmune Diseases/complications , Diabetes Mellitus, Type 1/complications , Insulin/metabolism , Islets of Langerhans/metabolism , Multiple Sclerosis/complications , Adrenal Cortex Hormones/therapeutic use , Adult , Antibodies, Antinuclear/blood , Aphasia/etiology , Brain/pathology , Confusion/etiology , Consciousness Disorders/etiology , Diabetes Mellitus, Type 1/physiopathology , Humans , Immunosuppressive Agents/therapeutic use , Insulin Resistance , Insulin Secretion , Magnetic Resonance Imaging , Male , Multiple Sclerosis/diagnosis , Multiple Sclerosis/pathologyABSTRACT
Between August 1995 and March 1997, 197 patients underwent 257 treatments for 217 stones by extracorporeal shock wave lithotripsy (ESWL) using a Lithodiagnost M (Philips, Holland). There were 149 males and 48 females with an average age of 50.6 years, ranging from 15 to 85 years. There were 53 stones located in the renal pelvis and calices (R2), 20 stones at the pelvi-ureteric junction (PUJ) (R3), 101 stones in the upper ureter (U1), 15 stones in the middle ureter (U2) and 28 stones in the lower ureter (U3). The average number of sessions was 1.18 and the average number of shock waves per stone was 3,546. Efficacy was evaluated 3 months after the final ESWL. The success rate was 95.4% (207/217), with complete disappearance of stones in 71.4% (155/217) and residual stones of less than 4 mm diameter in 24% (52/217). No severe complications, except for subcapsular renal hematoma in one patient, were observed. These results indicate that almost all upper urinary tract stones can be successfully treated by ESWL monotherapy.
